Inge Lassen-Nordgaard

Hvidovre, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Probiotic Treatment of Ulcerative Colitis with Trichuris Suis Ova: A Randomised, Double-blinded, Placebo-controlled Clinical Trial [the PROCTO Trial].

Probiotic Treatment of Ulcerative Colitis with Trichuris Suis Ova: A Randomised, Double-blinded, Placebo-controlled Clinical Trial [the PROCTO Trial].

Journal: Journal of Crohn's & colitis

Published: June 20, 2024

The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020.

The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010-2020.

Journal: Crohn's & colitis 360

Published: August 25, 2022

Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial.

Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial.

Journal: Scandinavian journal of gastroenterology

Published: February 12, 2019

Challenges and obstacles in the transition process through the eyes of the gastroenterologist.

Challenges and obstacles in the transition process through the eyes of the gastroenterologist.

Journal: European journal of gastroenterology & hepatology

Published: January 29, 2019

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease.

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease.

Journal: Frontiers in medicine

Published: March 21, 2018

S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery.

S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery.

Journal: Obesity facts

Published: February 01, 2017

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.

Journal: Inflammatory bowel diseases

Published: February 27, 2016

Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites.

Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites.

Journal: Scandinavian journal of gastroenterology

Published: December 18, 2015

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis.

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis.

Journal: Scientific reports

Published: December 15, 2015

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: April 20, 2015

Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases.

Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases.

Journal: Scandinavian journal of gastroenterology

Published: April 17, 2015

The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.

The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients.

Journal: Journal of Crohn's & colitis

Published: March 31, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026